Skip to main content

BLAU3 · Blau Farmacêutica S.A. · Financials

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Revenue
1.7B -3%
FY2025 Revenue FY2017–FY2025
Net Income
294.96M +35.8%
FY2025 Net Income FY2017–FY2025
Gross Margin
40.1% +2.6pp
FY2025 Gross Margin FY2017–FY2025
Operating Cash Flow
290.84M -42.7%
FY2025 Operating Cash Flow FY2017–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
BRL 1.82B 1.7B 1.75B 1.37B 1.41B 1.37B 1.18B 977.5M 782.17M 617.66M
BRL 1.05B 1.02B 1.1B 882.38M 739.03M 700.47M 625.84M 547.44M 443.91M 337.22M
BRL 764.39M 682.74M 658.75M 490.25M 667.88M 665.93M 555.97M 430.07M 338.26M 280.43M
BRL 249.2M 388.47M 291.89M 334.23M 468.56M 482.47M 353.64M 286.36M 178.4M 148.49M
BRL 51.03M 91.7M 78.36M 86.74M 108.07M 158.6M 99.31M 86.13M 55.15M 45.36M
BRL 198.9M 294.96M 217.21M 249.81M 360.49M 325.22M 254.33M 200.24M 123.25M 103.13M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.